Johnson and Johnson executive splits for the corner office at Itamar Medical | Personnel Moves

May 24, 2013 By Sony Salzman

Former J&J executive joins Itamar Medical as CEO
Gilad Glick will leave his job as head of Johnson & Johnson’s (NYSE:JNJ) global cardiology division to become the CEO of Itamar Medical in July.

The Caesarea, Israel-based medical device maker said current CEO, Dov Rubin, will step down after serving for 5 years. The company calls this a "pivotal point of transitionally into an accelerated commercial stage."

Glick joined Biosense Webster while it was still a small start up, before it was sold to Johnson and Johnson as part of company’s cardiovascular division. While at Johnson and Johnson, Glick served as VP of worldwide sales and marketing and as a senior member of the Biosense team.
Read more

Interim CEO step up, VP of finance steps down at Vision-Sciences
Vision-Sciences Inc. (NSDQ:VSCI) appointed an interim CEO to replace Cynthia Ansari, who stepped down after 2 years at the job. Howard I. Zauberman was appointed based on his 30 years of experience in the medical device industry. The Orangeburg, S.C.-based endoscopic device maker also announced resignation of Keith Darragh, the company’s VP of finance and accounting officer.
Read more

New VP of global sales and marketing at Misonix

Misonix (NSDQ:MSON) appointed Scott Ludecker VP of global sales and marketing. He joins the company from the same role at BioMimetic Therapeutics. Ludecker has more than 20 years experience in the global medical device industry, most recently at BioMimetic and Small Bone Innovations. According to the April 8 offer letter, Ludecker will receive a base salary of $200,000 and report directly to CEO Michael McManus, Jr.
Read more

Third Rock Ventures pulls in industry executives
Venture capital firm Third Rock recently appointed several new executives from large pharmaceutical and medical device companies.

The Boston, Mass.-based VC named James Geraghty as entrepreneur-in-residence. Geraghty comes to Third Rock with 20 years experience at Genzyme Corporation. Steven Paul will be stepping up his role as a venture partner. He is a former Lilly Research Labs president and director of the Helen & Robert Appel Institute for Alzheimer’s Research at Weill Cornell Medical College. Daniel Lynch, former CEO of ImClone Systems, will transition from entrepreneur-in-residence to a venture partner. John Maraganore, CEO of Alnylam, also joined the Third Rock as a venture partner.
Read more

New CEO joins Accumed Radial Systems
Michael Pisano joined Accumed Radial Systems as president and CEO. Pisano will lead the the newly formed wholly owned subsidiary of Accumed Systems, Inc. The newly formed Accumed Radial Systems was created after successful roll out of several transradial procedures by Accumed Systems, which decided to create the subsidiary to focus solely on this market. Pisano formerly worked as CEO of NextGen Group.
Read more

Using gold nanoparticles to detect COVID-19
Scientists from the University of Maryland School of Medicine have developed an experimental diagnostic test for COVID-19 that they say can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require… […]
Jama Software debuts medtech software
Jama Software (Portland, Ore.) announced this week that it has introduced new software for medical device development. The company described Jama Connect as a solution designed to help engineering teams better manage device requirements, risk and design control. The new software is also designed to make regulatory submissions and audit preparations a straightforward process and… […]
Could this fabric protect against a strain of coronavirus?
Noble Biomaterials announced today that third-party testing showed one of its metallized fabrics reduced the viability of a common, strong strain of coronavirus. In testing conducted by BioScience Laboratories, Noble Biomaterials’ X-Static fabric reduced the survival of human coronavirus OC43 six times faster than the unmetallized control fabric, according to the Scranton, Pa.-based company. X-Static… […]
How gas and liquid valves improve medtech performance and efficiency
While the miniature solenoid valves might be simple in their core technology, their continued evolution makes them valuable and effective components for controlling the flow, direction and pressure of gases and fluids in today’s medical devices. Paul Gant, Emerson Automation Solutions With automated functions, excellent reliability and long life, it’s no surprise that gas and liquid… […]
Astrodyne TDI and Digi-Key Electronics join forces
Power supply and EMI filter manufacturer Astrodyne TDI announced today that it has joined Digi-Key Electronics’ DK+ Marketplace, a new B2B electronics sales site open to suppliers and distributors to offer their products and services on DigiKey.com. This new venture will make Astrodyne TDI’s medical and industrial power solutions available for immediate delivery to Digi-Key’s engineering… […]
How to meet challenges with innovative machining
CNC is a technique for automating control of machine tools using software rooted in a microcomputer affixed to the tool. It is frequently used in manufacturing for machining metal and plastic parts. John Cross, Micro Data drive the accuracy and efficiency of the computerized numerical control (CNC) machines coming onto the market today. The latest… […]
Vexos to manufacture 10,000 ventilators for Canadian COVID-19 patients
Electronics manufacturer Vexos said this week that it has signed an agreement with the government of Canada to manufacture 10,000 mechanical ventilators for COVID-19 patients in that country. The LaGrange, Ohio-based company said it will build the ventilators, known as Mechanical Ventilator Milano (MVM), under an exclusive license agreement with Elemaster Group for the Americas. Vexos said… […]
Merck eyes tiny patches as a vaccine delivery method
Merck has exercised its option to use Vaxxas‘ High Density Microarray Patch (HD-MAP) platform as a delivery platform for a vaccine candidate, the companies announced today. The companies did not disclose what the vaccine candidate is supposed to treat. But Merck this month announced two COVID-19 vaccine development efforts: a collaboration with IAVI and plans… […]
Qioptiq to build new plant in Germany
Qioptiq announced today that it has begun construction on a new factory in Germany. A subsidiary of Excelitas Technologies, Qioptiq will invest about $27 million in the project. Located in the Göttingen Science Park industrial estate, the new site has an initial acreage of approximately 193,750 sq. ft. and will house state-of-the-art ISO 5 cleanrooms… […]
Pioneer Metal Finishing launches surface tech resource
Pioneer Metal Finishing (Green Bay, Wis.) recently announced the launch of Surface Engineering Academy (SEA), an expert-level resource for surface engineering and modification advancement. SEA’s focus on surface engineering and modification stems from the company’s goal to further develop and apply optimized product surfaces. Legacy technologies such as anodizing, plating, adhesives and coatings continue to… […]
Texas-based team seeks EUA for 3D printed emergency ventilator
A team of physicians and engineers developed a hands-free resuscitator bag compression device that can be utilized as an emergency ventilator during the COVID-19 pandemic. As the pandemic goes on and a shortage of vital equipment, including ventilators, continues, a number of companies and research teams from all over have worked to create alternative options. One… […]